Renal cell carcinoma von Jonasch, Eric, Gao, Jianjun, Rathmell, W Kimryn

Volltext

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality von Jonasch, Eric, Walker, Cheryl Lyn, Rathmell, W. Kimryn

Volltext

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages von Obradovic, Aleksandar, Chowdhury, Nivedita, Haake, Scott M., Ager, Casey, Wang, Vinson, Vlahos, Lukas, Guo, Xinzheng V., Aggen, David H., Rathmell, W. Kimryn, Jonasch, Eric, Johnson, Joyce E., Roth, Marc, Beckermann, Kathryn E., Rini, Brian I., McKiernan, James, Califano, Andrea, Drake, Charles G.

Volltext

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma von Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric

Volltext

Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer von McGrail, Daniel J., Garnett, Jeannine, Yin, Jun, Dai, Hui, Shih, David J.H., Lam, Truong Nguyen Anh, Li, Yang, Sun, Chaoyang, Li, Yongsheng, Schmandt, Rosemarie, Wu, Ji Yuan, Hu, Limei, Liang, Yulong, Peng, Guang, Jonasch, Eric, Menter, David, Yates, Melinda S., Kopetz, Scott, Lu, Karen H., Broaddus, Russell, Mills, Gordon B., Sahni, Nidhi, Lin, Shiaw-Yih

Volltext

The PI3K/AKT Pathway and Renal Cell Carcinoma von Guo, Huifang, German, Peter, Bai, Shanshan, Barnes, Sean, Guo, Wei, Qi, Xiangjie, Lou, Hongxiang, Liang, Jiyong, Jonasch, Eric, Mills, Gordon B., Ding, Zhiyong

Volltext

Alternate sunitinib schedules in patients with metastatic renal cell carcinoma von Kalra, S., Rini, B.I., Jonasch, E.

Volltext

Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis von Liu, X-D, Yao, J, Tripathi, D N, Ding, Z, Xu, Y, Sun, M, Zhang, J, Bai, S, German, P, Hoang, A, Zhou, L, Jonasch, D, Zhang, X, Conti, C J, Efstathiou, E, Tannir, N M, Eissa, N T, Mills, G B, Walker, C L, Jonasch, E

Volltext

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma von Zhang, Jing, Wu, Tao, Simon, Jeremy, Takada, Mamoru, Saito, Ryoichi, Fan, Cheng, Liu, Xian-De, Jonasch, Eric, Xie, Ling, Chen, Xian, Yao, Xiaosai, Teh, Bin Tean, Tan, Patrick, Zheng, Xingnan, Li, Mingjie, Lawrence, Cortney, Fan, Jie, Geng, Jiang, Liu, Xijuan, Hu, Lianxin, Wang, Jun, Liao, Chengheng, Hong, Kai, Zurlo, Giada, Parker, Joel S, Auman, J Todd, Perou, Charles M, Rathmell, W Kimryn, Kim, William Y, Kirschner, Marc W, Kaelin, Jr, William G, Baldwin, Albert S, Zhang, Qing

Volltext

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma von Porten, Sima, Siefker‐Radtke, Arlene O., Xiao, Lianchun, Margulis, Vitaly, Kamat, Ashish M., Wood, Christopher G., Jonasch, Eric, Dinney, Colin P. N., Matin, Surena F.

Volltext

Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy von Ye, Youqiong, Hu, Qingsong, Chen, Hu, Liang, Ke, Yuan, Yuan, Xiang, Yu, Ruan, Hang, Zhang, Zhao, Song, Anren, Zhang, Huiwen, Liu, Lingxiang, Diao, Lixia, Lou, Yanyan, Zhou, Bingying, Wang, Li, Zhou, Shengtao, Gao, Jianjun, Jonasch, Eric, Lin, Steven H., Xia, Yang, Lin, Chunru, Yang, Liuqing, Mills, Gordon B., Liang, Han, Han, Leng

Volltext

Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease von Wiley, Henry E., Srinivasan, Ramaprasad, Maranchie, Jodi K., Chhablani, Jay, Iversen, Ane Bundsbæk Bøndergaard, Kruse, Anders, Jonasch, Eric, Gombos, Dan S., Else, Tobias, Demirci, Hakan, Maughan, Benjamin L., Hartnett, M. Elizabeth, Coleman, Hanna R., Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Chew, Emily Y., Welsh, Sarah, Thavikulwat, Alisa T., Keenan, Tiarnan D.L., Bellur, Sunil, Mac, Lisa, Cukras, Catherine A.

Volltext

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial von Jonasch, Eric, McCutcheon, Ian E, Gombos, Dan S, Ahrar, Kamran, Perrier, Nancy D, Liu, Diane, Robichaux, Christine C, Villarreal, Mercedes F, Weldon, Justin A, Woodson, Ashley H, Pilie, Patrick G, Fuller, Gregory N, Waguespack, Steven G, Matin, Surena F

Volltext

Sunitinib-Related Osteonecrosis of the External Auditory Canal: Case Report von Eguia, Arturo, Jonasch, Eric, Gidley, Paul

Volltext

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement von Bratslavsky, Gennady, Mendhiratta, Neil, Daneshvar, Michael, Brugarolas, James, Ball, Mark W., Metwalli, Adam, Nathanson, Katherine L., Pierorazio, Phillip M., Boris, Ronald S., Singer, Eric A., Carlo, Maria I., Daly, Mary B., Henske, Elizabeth P., Hyatt, Colette, Middleton, Lindsay, Morris, Gloria, Jeong, Anhyo, Narayan, Vivek, Rathmell, W. Kimryn, Vaishampayan, Ulka, Lee, Bruce H., Battle, Dena, Hall, Michael J., Hafez, Khaled, Jewett, Michael A. S., Karamboulas, Christina, Pal, Sumanta K., Hakimi, A. Ari, Kutikov, Alexander, Iliopoulos, Othon, Linehan, W. Marston, Jonasch, Eric, Srinivasan, Ramaprasad, Shuch, Brian

Volltext

Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects von Simon, Jeremy M, Hacker, Kathryn E, Singh, Darshan, Brannon, A Rose, Parker, Joel S, Weiser, Matthew, Ho, Thai H, Kuan, Pei-Fen, Jonasch, Eric, Furey, Terrence S, Prins, Jan F, Lieb, Jason D, Rathmell, W Kimryn, Davis, Ian J

Volltext

Guidelines for surveillance of patients with von Hippel‐Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance von Daniels, Anthony B., Tirosh, Amit, Huntoon, Kristin, Mehta, Gautam U., Spiess, Philippe E., Friedman, Debra L., Waguespack, Steven G., Kilkelly, Jill E., Rednam, Surya, Pruthi, Sumit, Jonasch, Eric A., Baum, Laura, Chahoud, Jad

Volltext

State of the science: an update on renal cell carcinoma von Jonasch, Eric, Futreal, P Andrew, Davis, Ian J, Bailey, Sean T, Kim, William Y, Brugarolas, James, Giaccia, Amato J, Kurban, Ghada, Pause, Armin, Frydman, Judith, Zurita, Amado J, Rini, Brian I, Sharma, Pam, Atkins, Michael B, Walker, Cheryl L, Rathmell, W Kimryn

Volltext

Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study von Shah, Amishi Y., Karam, Jose A., Malouf, Gabriel G., Rao, Priya, Lim, Zita D., Jonasch, Eric, Xiao, Lianchun, Gao, Jianjun, Vaishampayan, Ulka N., Heng, Daniel Y., Plimack, Elizabeth R., Guancial, Elizabeth A., Fung, Chunkit, Lowas, Stefanie R., Tamboli, Pheroze, Sircar, Kanishka, Matin, Surena F., Kimryn Rathmell, W., Wood, Christopher G., Tannir, Nizar M.

Volltext

Phase 1b/2 trial of Ipilimumab, Nivolumab, and Ciforadenant (INC) (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma von Beckermann, Kathryn, Rini, Brian, Haas, Naomi, George, Daniel, Jonasch, Eric

Volltext